Novel Coronavirus Disease (COVID-19): A Narrative Review Based on Current Status

2020 ◽  
Vol 18 ◽  
Author(s):  
Rina Das ◽  
Dinesh Kumar Mehta ◽  
Meenakshi Dhanawat

Abstract:: A novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appeared and expanded globally by the end of year in 2019 from Wuhan, China, causing severe acute respiratory syndrome. During its initial stage, the disease was called the novel coronavirus (2019-nCoV). It was named COVID-19 by the World Health Organization (WHO) on 11 February 2020. The WHO declared worldwide the SARS-CoV-2 virus a pandemic on March 2020. On 30 January 2020 the first case of Corona Virus Disease 2019 (COVID-19) was reported in India. Now in current situation the virus is floating in almost every part of the province and rest of the globe. -: On the basis of novel published evidences, we efficiently summarized the reported work with reference to COVID-19 epidemiology, pathogen, clinical symptoms, treatment and prevention. Using several worldwide electronic scientific databases such as Pubmed, Medline, Embase, Science direct, Scopus, etc were utilized for extensive investigation of relevant literature. -: This review is written in the hope of encouraging the people successfully with the key learning points from the underway efforts to perceive and manage SARS-CoV-2, suggesting sailent points for expanding future research.

2020 ◽  
Author(s):  
Stephanie Gabriele Werner ◽  
Hans-Eckhard Langer

Abstract Background: The novel coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) and its associated disease COVID‐19 (Corona Virus Disease 19) has become a worldwide pandemic since its first cases in December 2019 in Wuhan Province in China. In Germany the pandemic started in February 2020.Case presentation: A 4 year old boy was presented and suffered from pain in the right hip. Arthrosonography demonstrated a significant effusion in the involved joint. The extended history revealed a slight but long lasting cold before. Serological findings were inconspicuous except for positive ELISA (Enzyme-linked Immuno Sorbent Assay) - test for SARS-CoV-2. Conclusion: In conclusion we believe that we can report the first case of reactive arthritis associated with SARS-CoV-2 in children.


Author(s):  
Ajay Chauhan ◽  
Asmita Gupta ◽  
Kari Suguna ◽  
Shashikant Shukla ◽  
Parul Goyal

The novel Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection can present with a multitude of clinical symptoms. The virus, disease symptomatology, pathogenesis and complications are being studied and new concepts are evolving rapidly. The current worldwide situation caused by the disease makes it exceedingly important to recognise varied presentations of the disease. Three cases are being discussed hereby, wherein the patients presented with altered sensorium secondary to hyponatremia as the initial and only presentation of SARS-CoV-2 infection, in the absence of fever or any respiratory involvement. Acute symptomatic hyponatremia is an under-recognised presentation with only a few cases reported till date and needs further awareness and understanding.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 54-61 ◽  
Author(s):  
Madhurya Kadavakollu ◽  
Veera Venkata Satyanarayana Reddy Karri ◽  
Kuppusamy Gowthamarajan ◽  
Arun Radhakrishnan ◽  
Dhanabal Palanisamy ◽  
...  

In the mid-end of December 2019, several cases of pneumonia outbreak of unknown cause and etiology were identified in Wuhan City of Hubei province in China, a city with a population of over 11 million.Till date(April 2020) around 1,051,635 confirmed cases of coronavirus disease 2019(COVID-19) and 56,985 confirmed deaths have been reported according to COVID-19 Situation Report – 75 by WHO. On 7th January 2020, the causative agent was identified and named consequently as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by the Chinese Centre for Disease Control and Prevention (CCDC) from throat swab samples. Later, on 12th January 2020, this coronavirus was named as 2019-novel coronavirus (2019-nCoV) by World Health Organization (WHO) and in 11th February 2020,it has been declared the epidemic disease caused by SARS-CoV-2 as Corona Virus Disease 2019(COVID-19) as it is spreading rapidly from its origin in Wuhan City to the rest of the world. In this context, the current review provides a landscape of the novel Corona Virus including its origin, transmission, epidemiology, drugs and vaccines in clinical trials for better understanding to the reads and peoples the status and future perspectives of this pandemic disease


2020 ◽  
Vol 22 (1-2) ◽  
pp. 93-98
Author(s):  
Niranjan Nayak ◽  
SK Rai

At present, a novel Corona Virus called Severe Acute Respiratory Syndrome corona virus (SARS-Cov-2) has caused pandemic infection. This virus has been thought to be of zoonotic origin specially originating from bats. This Virus originated from wet market in Wuhan, China in December 2019. A small cluster of Pneumonia cases that occured in Wuhan in December 2019 was named COVID-19 (Corona Virus Disease) by World Health Organization (WHO). The Covid-19 is still on the rise across the globe. As there is no treatment available for the SARS-Cov-2, it is important to mantain social distance, practice frequent hand-washing and use mask.


2020 ◽  
Author(s):  
Ugochinyere Ijeoma Nwagbara ◽  
Emmanuella Chinonso Osuala ◽  
Rumbidzai Chireshe ◽  
Obasanjo Afolabi Bolarinwa

Abstract Background: Recent statistics and studies have shown the adverse effects of the novel coronavirus 2019 (COVID-19) on population health and how knowledge, attitude, perception and practice (KAP) towards the virus can be the main key to limiting its spread in the absence of a vaccine. Thus, this study aims at mapping evidence on the KAP towards COVID-19 in sub-Saharan Africa (SSA) using scoping review.Methods: The study will employ a systematic scoping review to identify, describe, and map literature on the KAP towards COVID-19 in SSA. The primary search will include peer-reviewed and grey literature. The search will be performed using the EBSCOhost platform and a keyword search from the following electronic databases will be conducted: PubMed/MEDLINE, Google Scholar, Science Direct, World Health Organization (WHO) library, and grey literature. The study selection will be guided by the inclusion and exclusion criteria. A data charting table will be used to extract information from the included studies. Data will be analysed using NVIVO version 10 and a thematic content analysis will be used to present narrative account of the review.Discussion: We anticipate finding relevant literature on the KAP towards COVID-19 in SSA. The results of this study will help reveal research gaps in KAP towards COVID-19 and this will guide future research and highlight the new concepts discovered. Systematic review protocol registration: Open Science Framework https://osf.io/sdm46/.


2020 ◽  
Vol 18 ◽  
Author(s):  
Deepika Paliwal ◽  
Shoaib Khan ◽  
Anindita Chaki

: Corona viruses (CoV) are known respiratory pathogen causing a major pandemic such as, severe acute respiratory syndrome (SARS, Middle East respiratory syndrome (MERS) and corona virus disease 2019 COVID-19). The World Health Organization (WHO) has acknowledged that recent outbreak as a global public health emergency. Presently, the study on novel coronavirus is still in the primary stage. Based on the current data, we summarizes the clinical characteristics, pathogenesis, diagnosis, treatment and prevention of information regarding COVID-19. In this mini-review, we aims at investigating the most recent trend of COVID-19 for helping the community effectively recognize and deal with the 2019 novel coronavirus (SARS-CoV-2), and providing a reference for forthcoming studies.


Author(s):  
Francesco Di Gennaro ◽  
Damiano Pizzol ◽  
Claudia Marotta ◽  
Mario Antunes ◽  
Vincenzo Racalbuto ◽  
...  

At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus a global pandemic. We performed a narrative review to describe existing literature with regard to Corona Virus Disease 2019 (COVID-19) epidemiology, pathophysiology, diagnosis, management and future perspective. MEDLINE, EMBASE and Scopus databases were searched for relevant articles. Although only when the pandemic ends it will be possible to assess the full health, social and economic impact of this global disaster, this review represents a picture of the current state of the art. In particular, we focus on public health impact, pathophysiology and clinical manifestations, diagnosis, case management, emergency response and preparedness.


2020 ◽  
Vol 9 (2) ◽  
pp. 1083-1088

Coronavirus disease (COVID-19) is a contagious disease triggered by the novel coronavirus. A novel coronavirus was observed as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). In December 2019, a disruption of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections appeared in Wuhan, Hubei Province, China and spread across China and beyond. In India, the first case of CORONA virus was reported in Kerala state on 30 January 2020. The most common symptoms of COVID-19 are fever, cough, shortness of breath, and breathing difficulties. In more severe cases infection can give rise to pneumonia, severe acute respiratory syndrome, and even death. The period within which the symptoms would appear is 1-14 days i.e. the incubation period of COVID-19. The present review highlights the types, etiology, transmission stages, manifestations, prevention, therapeutic options, learning points from outbreak, and initiative taken by Government of India (GOI) to control the spread of literary deathly disease.


2020 ◽  
Vol 54 (11) ◽  
pp. 1067-1071 ◽  
Author(s):  
Eric J Tan ◽  
Denny Meyer ◽  
Erica Neill ◽  
Andrea Phillipou ◽  
Wei Lin Toh ◽  
...  

During this unprecedented novel coronavirus (COVID-19) pandemic, there is an urgent need for empirical data to characterise its impact on the mental health and well-being of Australians. In this viewpoint, we outline a number of considerations for research on this topic, highlighting areas necessitating special attention, consideration of particular vulnerable groups and the need for longitudinal studies to track mental health fluctuations in the general population. We conclude by introducing the COLLATE (COvid-19 and you: mentaL heaLth in AusTralia now survEy) project, outlining its aims, addressing some considerations raised herein and detailing avenues for future research. Since the World Health Organization (WHO) declared the novel coronavirus (COVID-19) outbreak a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 (WHO, 2020), the COVID-19 pandemic has caused major upheaval both in Australia and globally. While the search for a vaccine continues, current efforts towards tackling the virus and limiting contagion in several nations have focused on social distancing and the shutdown of non-essential services. In Australia, the first case was reported on 13 January 2020 (COVID-19 National Incident Room Surveillance Team, 2020), the first death occurred on 24 February and a spate of progressive restrictions were enforced throughout the 2 weeks leading up to 31 March 2020 (COVID-19 National Incident Room Surveillance Team, 2020a).


Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1145
Author(s):  
Hakimeh Baghaei Daemi ◽  
Muhammad Fakhar-e-Alam Kulyar ◽  
Xinlin He ◽  
Chengfei Li ◽  
Morteza Karimpour ◽  
...  

Influenza is a highly known contagious viral infection that has been responsible for the death of many people in history with pandemics. These pandemics have been occurring every 10 to 30 years in the last century. The most recent global pandemic prior to COVID-19 was the 2009 influenza A (H1N1) pandemic. A decade ago, the H1N1 virus caused 12,500 deaths in just 19 months globally. Now, again, the world has been challenged with another pandemic. Since December 2019, the first case of a novel coronavirus (COVID-19) infection was detected in Wuhan. This infection has risen rapidly throughout the world; even the World Health Organization (WHO) announced COVID-19 as a worldwide emergency to ensure human health and public safety. This review article aims to discuss important issues relating to COVID-19, including clinical, epidemiological, and pathological features of COVID-19 and recent progress in diagnosis and treatment approaches for the COVID-19 infection. We also highlight key similarities and differences between COVID-19 and influenza A to ensure the theoretical and practical details of COVID-19.


Sign in / Sign up

Export Citation Format

Share Document